Evidence map›Paper›PMID 36711018›Full record

ArticleFrontiers in physiology2023

Derivatives of 2-aminobenzimidazole potentiate ASIC open state with slow kinetics of activation and desensitization.

Konstantin K Evlanenkov, Margarita S Komarova, Mikhail Y Dron, Maxim V Nikolaev, Olga N Zhukovskaya, Nataliya A Gurova, Denis B Tikhonov

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Konstantin K EvlanenkovI.M. Sechenov Institute of Evolutionary Physiology and Biochemistry, St. Petersburg, Russia.
Margarita S KomarovaI.M. Sechenov Institute of Evolutionary Physiology and Biochemistry, St. Petersburg, Russia.
Mikhail Y DronI.M. Sechenov Institute of Evolutionary Physiology and Biochemistry, St. Petersburg, Russia.
Maxim V NikolaevI.M. Sechenov Institute of Evolutionary Physiology and Biochemistry, St. Petersburg, Russia.
Olga N ZhukovskayaResearch Institute of Physical and Organic Chemistry, Southern Federal University, Rostov-on-Don, Russia.
Nataliya A GurovaDepartment of Pharmacology and Bioinformatics, Volgograd State Medical University, Volgograd, Russia.
Denis B TikhonovI.M. Sechenov Institute of Evolutionary Physiology and Biochemistry, St. Petersburg, Russia.
Institute of Evolutionary Physiology and Biochemistry · RUSouthern Federal University · RUVolgograd State Medical University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pharmacology of acid-sensitive ion channels (ASICs) is diverse, but potent and selective modulators, for instance for ASIC2a, are still lacking. In the present work we studied the effect of five 2-aminobenzimidazole derivatives on native ASICs in rat brain neurons and recombinant receptors expressed in CHO cells using the whole-cell patch clamp method. 2-aminobenzimidazole selectively potentiated ASIC3. Compound Ru-1355 strongly enhanced responses of ASIC2a and caused moderate potentiation of native ASICs and heteromeric ASIC1a/ASIC2a. The most active compound, Ru-1199, caused the strongest potentiation of ASIC2a, but also potentiated native ASICs, ASIC1a and ASIC3. The potentiating effects depended on the pH and was most pronounced with intermediate acidifications. In the presence of high concentrations of Ru-1355 and Ru-1199, the ASIC2a responses were biphasic, the initial transient currents were followed by slow component. These slow additional currents were weakly sensitive to the acid-sensitive ion channels pore blocker diminazene. We also found that sustained currents mediated by ASIC2a and ASIC3 are less sensitive to diminazene than the peak currents. Different sensitivities of peak and sustained components to the pore-blocking drug suggest that they are mediated by different open states. We propose that the main mechanism of action of 2-aminobenzimidazole derivatives is potentiation of the open state with slow kinetics of activation and desensitization.

Indexed as

ion channelskinetics of actionmodulationpharmacologystructure-function relationships

Identifiers

PMID36711018
PMCPMC9878307
OpenAlexW4315782101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.